Linagliptin 5 mg & Dapagliflozin 10 mg ''''

Linagliptin 5 mg & Dapagliflozin 10 mg
LINALIGLIP DAPA 5-10  
Linagliptin is an oral medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor.
It helps control blood sugar levels by increasing the levels of incretin hormones in the body, which stimulate the release of insulin and inhibit the release of glucagon. This leads to reduced blood sugar levels after meals.
Dapagliflozin is a medication classified as a sodium-glucose cotransporter-2 (SGLT2) inhibitor.
It works by blocking the reabsorption of glucose in the kidneys, allowing excess glucose to be excreted in the urine. This mechanism helps lower blood sugar levels.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-dapa-5-10-134320